MT
MindImmune Therapeutics, Inc.
SEC filingPharmaceuticals · Kingston, RI
Amount raised$15.2Msold at filing
Total offering$17M$1.8M still open
Investors in the raise15count reported to the SEC
FiledMar 5, 2026first sale Nov 24, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Reetika BhardwajDirector
Christopher O'DonnellDirector
Bradley MargusDirector
Isaac StonerExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.